Spontaneous tendon healing may result in reduced tissue functionality. In view of this, tissue 31 engineering (TE) emerges as a promising approach in promoting proper tendon regeneration. 32 However, unfavourable post-surgical adhesion formations restrict adequate tendon healing 33 through the TE approach. Naproxen sodium (NPS), a non-steroidal anti-inflammatory drug 34 (NSAID), has been demonstrated to prevent adhesions by inhibiting inflammatory response. 35 Therefore, in this work, various factors, i.e. polymer composition (i.e. different poly-l-lactic acid 36 (PLLA) to polycaprolactone (PCL) ratios) and percentage of water (H 2 O) to 37 hexafluoroisopropanol (HFIP) as co-solvent, were investigated to understand how these can 38 influence the release of NPS from electrospun scaffolds. By adjusting the amount of H 2 O as the 39 co-solvent, NPS could be released sustainably for as long as two weeks. Scaffold breaking strength 40 was also enhanced with the addition of H 2 O as the co-solvent. This NPS-loaded scaffold showed 41 no significant cytotoxicity, and L929 murine fibroblasts cultured on the scaffolds were able to 42 proliferate and align along the fiber orientation. These scaffolds with desirable tendon TE 43 characteristics would be promising candidates in achieving better tendon regeneration in vivo. 44 45
Introduction 49 According to statistics in the United States, 15 million musculoskeletal injuries involving the 50 impairment of tendon and ligament are reported annually. Owing to the low cellularity and 51 vascularity of these organs (Strauss et al., 2007) , spontaneous healing commonly results in 52 reduced tissue functionality (Sharma and Maffulli, 2006) . In view of this, tissue engineering (TE) 53 has emerged as a promising field that seeks to offer viable solutions to tissue regeneration, 54 including tendon; whereby a three dimensional (3D) scaffold mimicking the cell 55 microenvironment can be used to regenerate new tendon tissues. Key features of this scaffold 56 include good biocompatibility, comparable degradation and tissue regeneration rates, and its 57 degraded by-products must be safely eliminated through natural metabolic pathways ( Adhesion formation, the result of overwhelming inflammatory response at the surgical site, 74 refers to abnormal adherence of soft tissue to surrounding structures. Many factors, including 75 surgical trauma, thermal injury, infection, foreign bodies and ischemia, could contribute to this 76 undesirable fibrous ingrowth (Liakakos et al., 2001) . Generally, during the tendon healing 77 process, collagen will be secreted to restore the continuity of injured tendon fibrils. However, at 78 the same time, there are large numbers of inflammatory cells being recruited to the injury site. 79 Their unfavourable integration with fibrils between the tendon and sheath results in scar tissue 80 formation that interferes with the gliding function of the tendon, eventually causing recurrent 81 injury or loss of function (Sharma and Maffulli, 2006 However, there are some inconsistencies in the results reported from these. There are also studies 86 that developed materials such as polyethylene tubes (Gonzalez, 1949) , hydroxyapatite (Siddiqi et   87 al., 1995) and silastic (Hunter and Salisbury, 1971 ) in a form of a pseudo-sheath to act as a 88 barrier between the repaired tendon and surrounding tissues. Some studies have also indicated 89 that the use of hyaluronic acid (Tanaka et al., 2007) , which is a polysaccharide found in synovial 90 fluid (Swann, 1978) , could also decrease the overall quantity of tendon adhesions. However, 91 there were still certain levels of adhesion tissue detected in the later stage of the experiments 92 (Thomas et al., 1986) .
94
One of the promising solutions in preventing adhesion formation is the prescription of NSAIDs, 95 in particular Naproxen Sodium (NPS). NPS is a hydrophilic drug that is widely used as a pain 96 reliever and also for the treatment of inflammation. burst release was observed for 90-10-5, 90-10-7, 90-10-10, but their subsequent release rates 228 were faster than 90-10-3. 90-10-5 could sustain the release of NPS for up to ten days, but release 229 was less than seven days for 90-10-7 and 90-10-10. It should be noted that the spectra obtained 230 were similar to the spectrum of the first day, indicating that there was no deterioration of the 231 NPS bioactivity throughout the experiment. 232 233
Contact Angle and Water Uptake

234
Contact angle and water uptake measurements were conducted to evaluate the hydrophilicities of 235 the scaffolds which would influence the associated release profiles. Figure 4 shows the contact 236 angles of various scaffolds in which the electrospinning solutions were prepared in different 237 formulations. Figure 4A shows that the contact angle of 90-10-0 scaffold was significantly 238 higher than that of 80-20-0 and 70-30-0. The introduction of H 2 O as co-solvent from 3 vol%, to 239 10 vol% gave no significant change in the contact angle (as shown in Figure 4B ). In order to achieve tendon regeneration through TE, it is important to consider not just a 292 biocompatible and mechanically sound scaffold that allows for good cell attachment and 293 proliferation, but also one that can avoid undesirable adhesion formations during tendon healing. 294 As such, the approach in this study is to achieve a sustained release of NPS from a biodegradable 295 scaffold that can minimize any adhesion formation (Cifkova et al., 1990; BAE and Kim, 1993) . 296 With this, several parameters were investigated, including polymer formulation, and the use of 297 H2O as a co-solvent with HFIP. Figure 9 ). XPS analysis in Figure 6 shows that there was also lower amount of NPS on the fiber 346 surface when 3 vol% of H 2 O was introduced, hence indicating that more NPS resided in the core 347 of the fiber (Figure 9) These scaffolds were also evaluated for their biocompatibility and ability to induce cell response. 384 Immortalized L929 murine fibroblasts were used as recommended by ASTM (ASTM F813-07: 
